Insider tradingForm 4
VERACYTE, INC. (VCYT) Insider Trading
7 open-market trades reported since Sep 3, 2026: 0 purchases worth $0 and 7 sales worth $1.39M.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Muna Bhanji | Director | 0 | $0 | 2 | $162K |
| John Leite | Global Chief Commercial Off | 0 | $0 | 1 | $161K |
| Jens Holstein | Director | 0 | $0 | 1 | $205K |
| Phillip G. Febbo | Chief Scientific & Med Officer | 0 | $0 | 1 | $564K |
| Rebecca Chambers | CFO | 0 | $0 | 1 | $157K |
| Annie McGuire | General Counsel | 0 | $0 | 1 | $140K |
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 20 | Muna BhanjiDirector | ▼ SELL10b5-1 | $81K | |
| Sep 22 | John LeiteGlobal Chief Commercial Off | ▼ SELL10b5-1 | $161K | |
| Sep 16 | Jens HolsteinDirector | ▼ SELL10b5-1 | $205K | |
| Sep 4 | Phillip G. FebboChief Scientific & Med Officer | ▼ SELL10b5-1 | $564K | |
| Sep 4 | Rebecca ChambersCFO | ▼ SELL10b5-1 | $157K | |
| Sep 4 | Annie McGuireGeneral Counsel | ▼ SELL10b5-1 | $140K | |
| Sep 3 | Muna BhanjiDirector | ▼ SELL10b5-1 | $80K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings